Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1999
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049883A2 Oxidized thymosin beta 4
10/07/1999WO1999049774A2 Methods for the diagnosis and treatment of lung cancer
10/07/1999WO1999049735A1 Mpr-related abc transporter encoding nucleic acids and methods of use thereof
10/07/1999WO1999045152A8 Methods for identifying polycationic, peptide-like compounds with antibacterial activity
10/07/1999WO1999042575A3 Calcium-activated potassium channel beta subunit gene and protein
10/07/1999WO1999040220A3 Method of screening therapeutic agents
10/07/1999WO1999040197A3 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
10/07/1999WO1999040182A3 CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF
10/07/1999WO1999040109A3 Recombinant mistletoe lectines
10/07/1999WO1999039174A3 An automatic method of classifying molecules
10/07/1999WO1999039001A3 Nucleic acid analysis method
10/07/1999WO1999038962A3 Compositions and methods for using a lysing matrix for isolating dna
10/07/1999WO1999037776A9 Methods for modulating angiogenesis
10/07/1999WO1999037768A9 Capon: a protein associated with neuronal nitric oxide synthase
10/07/1999WO1999036513A9 A herpes virus vector
10/07/1999WO1999036102A9 GENETIC MANIPULATION BY 3' UNTRANSLATED SEQUENCES OF mRNA
10/07/1999WO1999031273A3 Universal collection medium
10/07/1999WO1999031251A9 Method and means for producing high titer, safe, recombinant lentivirus vectors
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999029880A3 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors
10/07/1999WO1999029717A3 Postweaning multisystemic wasting syndrome virus from pigs
10/07/1999WO1999028465A3 Pias molecules that recognize and bind stat proteins and uses thereof
10/07/1999WO1999028461A3 Methods and means for inducing apoptosis by interfering with bip-like proteins
10/07/1999WO1999027131A3 Topologically fixed matrix bonded nucleic acid molecule
10/07/1999WO1999023221A3 Multivalent antigen-binding proteins
10/07/1999WO1999022005A3 Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
10/07/1999WO1999021996A9 Methods and compositions for the diagnosis and treatment of cataracts
10/07/1999WO1999015668A3 Banana proteins, dna, and dna regulatory elements associated with fruit development
10/07/1999DE19816395A1 Menschliche Nukleinsäuresequenzen aus Ovar-Normalgewebe Nucleic acid sequences from human ovarian normal tissue
10/07/1999DE19815368A1 New human liver cell line, useful for tetracycline-regulatable protein expression
10/07/1999DE19814963A1 MAPKAP Kinase 2-Hemmer und ihre Verwendung für die anti-inflammatorische Therapie MAPKAP kinase 2 inhibitors and their use for the anti-inflammatory therapy
10/07/1999DE19814925A1 Arzneimittel zur Induktion zytotoxischer T-Zellen Drugs for the induction of cytotoxic T cells
10/07/1999DE19814861A1 Neue Proteinvariante des NET1-Locus New protein variant of NET1 locus
10/07/1999DE19814860A1 Bakterielle Transglutaminasen Bacterial transglutaminases
10/07/1999DE19814528A1 Verfahren zur Erhöhung der POPS-Hydroxylierungsrate A method for increasing the POPs hydroxylation
10/07/1999DE19812940A1 Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung Formulation with papillomavirus-specific protein, its preparation and use
10/07/1999CA2735260A1 Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2401916A1 Recombinant anti-tumor rnase
10/07/1999CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
10/07/1999CA2333433A1 Salicylic acid pathway genes and their use for the induction of resistance in plants
10/07/1999CA2326573A1 Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
10/07/1999CA2326391A1 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999CA2325984A1 Oxidized thymosin beta 4
10/07/1999CA2325721A1 Corticotropin releasing factor receptor 1-deficient mice
10/07/1999CA2325564A1 Inducible alphaviral gene expression system
10/07/1999CA2325054A1 Amp deaminase
10/07/1999CA2325017A1 Collagen peptides and uses thereof
10/07/1999CA2324973A1 Method for increasing the phenoxy propionic acid hydroxylation rate
10/07/1999CA2324969A1 Pathogen-inducible promoter
10/07/1999CA2324654A1 Circular, hairpin, circular/hairpin, lariat, and hairpin-lariat hammerhead ribozymes
10/07/1999CA2324652A1 Nek1-related protein kinase
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999CA2324492A1 Secreted proteins and polynucleotides encoding them
10/07/1999CA2324477A1 Use of active p40 conjugates for nasal delivery
10/07/1999CA2324476A1 Treatment and prevention of vascular disease
10/07/1999CA2324445A1 Blk genes, gene products and uses thereof in apoptosis
10/07/1999CA2324444A1 P53-regulated genes
10/07/1999CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999CA2324440A1 Directed antisense libraries
10/07/1999CA2324424A1 Method for searching steroid sulfatase inhibitors
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999CA2324420A1 Method of suppressing gene expression in plants
10/07/1999CA2324286A1 Growth differentiation factor-9 regulatory sequences and uses therefor
10/07/1999CA2324229A1 Chimeric insecticidal protein and gene coding therefore
10/07/1999CA2323836A1 Novel sequence class of genes, corresponding proteins and the use of the same
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999CA2321179A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999CA2320491A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999CA2291798A1 Monoclonal antibody against human telomerase catalytic subunit
10/06/1999EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999EP0947582A1 A polypeptide structure for use as a scaffold
10/06/1999EP0947525A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
10/06/1999EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999EP0946754A1 Dna sequencing method
10/06/1999EP0946752A1 Method of sequencing dna based on the detection of the release of pyrophosphate
10/06/1999EP0946751A1 Atherothrombotic disorders: mutation in the factor xiii gene
10/06/1999EP0946748A1 Method for detection of mutations
10/06/1999EP0946747A2 Probes, methods and kits for detection and typing of helicobacter pylori nucleic acids in biological samples
10/06/1999EP0946744A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
10/06/1999EP0946743A1 A method of enhancing the rate of transfection of cells
10/06/1999EP0946742A1 Chimeric adenoviral vectors
10/06/1999EP0946741A1 Method for producing recombinant virus
10/06/1999EP0946740A1 Novel constructs and vectors for the targeted and inducible expression of genes
10/06/1999EP0946739A1 Antifungal polypeptide and methods for controlling plant pathogenic fungi
10/06/1999EP0946738A1 Binary methods of increasing accumulation of essential amino acids in seeds
10/06/1999EP0946737A2 Herbicide resistant plants
10/06/1999EP0946736A1 Method for expression of heterologous proteins in yeast
10/06/1999EP0946735A1 N-terminally extended proteins expressed in yeast
10/06/1999EP0946734A2 Preparation of pichia methanolica auxotrophic mutants
10/06/1999EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999EP0946732A2 Method for the recombinant production of 1,3-propanediol
10/06/1999EP0946731A1 Non-m non-o hiv strains, fragments and applications
10/06/1999EP0946730A2 Mutants of streptococcal toxin c and methods of use
10/06/1999EP0946729A2 Proteins with enhanced levels of essential amino acids
10/06/1999EP0946728A1 Bone stimulating factor
10/06/1999EP0946727A1 Antibody mutants
1 ... 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 3359 3360 3361 3362 3363 3364 3365 ... 4023